177 related articles for article (PubMed ID: 8283068)
1. Group specific component (Gc) in erythema nodosum leprosum (ENL).
Ghei SK; Agrewala JN; Sengupta U; Sudhakar KS
Indian J Lepr; 1993; 65(3):323-5. PubMed ID: 8283068
[TBL] [Abstract][Full Text] [Related]
2. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
[TBL] [Abstract][Full Text] [Related]
3. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
Gupta N; Shankernarayan NP; Dharmalingam K
J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
[TBL] [Abstract][Full Text] [Related]
4. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
5. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
[TBL] [Abstract][Full Text] [Related]
6. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
[TBL] [Abstract][Full Text] [Related]
7. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
Jain VK; Verma KC; Aggarwal SS
Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
[TBL] [Abstract][Full Text] [Related]
8. A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum.
Filley E; Andreoli A; Steele J; Waters M; Wagner D; Nelson D; Tung K; Rademacher T; Dwek R; Rook GA
Clin Exp Immunol; 1989 Jun; 76(3):343-7. PubMed ID: 2787714
[TBL] [Abstract][Full Text] [Related]
9. Erythema nodosum leprosum: report of two cases.
Aggarwal R; Gupta O; Beg S; Prasad R
Diagn Cytopathol; 2013 Apr; 41(4):366-8. PubMed ID: 21932352
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
[TBL] [Abstract][Full Text] [Related]
11. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
12. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
Foss NT; de Oliveira EB; Silva CL
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
[TBL] [Abstract][Full Text] [Related]
13. Increased level of urinary nitric oxide metabolites in leprosy patients during type 2 reactions and decreased after antireactional therapy.
Mohanty KK; Gupta M; Girdhar BK; Girdhar A; Chakma JK; Sengupta U
Lepr Rev; 2007 Dec; 78(4):386-90. PubMed ID: 18309713
[TBL] [Abstract][Full Text] [Related]
14. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
15. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
16. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
Sasiain MC; Ruibal Ares B; Baliña LM; Valdez R; Bachmann AE
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
[TBL] [Abstract][Full Text] [Related]
17. Erythema nodosum leprosum and orbital involvement.
Dhaliwal U; Mohanty S; Bhattacharya SN
Int J Lepr Other Mycobact Dis; 2003 Mar; 71(1):10-3. PubMed ID: 12914128
[TBL] [Abstract][Full Text] [Related]
18. Leukemoid reaction in erythema nodosum leprosum in a leprosy patient.
Chaudhary SD; Sen R; Jain VK; Dixit VB
Indian J Lepr; 1988 Oct; 60(4):572-6. PubMed ID: 3253336
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of erythema nodosum leprosum (type 2 reaction) by cytology.
Ray R; Mondal RK; Pathak S
Acta Cytol; 2014; 58(1):29-32. PubMed ID: 24247108
[TBL] [Abstract][Full Text] [Related]
20. [Review: update on erythema nodosum leprosum].
Morand JJ; Badiane C; Bobin P
Med Trop (Mars); 2004; 64(5):423-30. PubMed ID: 15771008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
